Baicalein enhances the antitumor efficacy of docetaxel on nonsmall cell lung cancer in a β‐catenin‐dependent manner
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Baicalein enhances the antitumor efficacy of docetaxel on nonsmall cell lung cancer in a β‐catenin‐dependent manner
Authors
Keywords
-
Journal
PHYTOTHERAPY RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-09-13
DOI
10.1002/ptr.6501
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- Exploring the chemopreventive properties and perspectives of baicalin and its aglycone baicalein in solid tumors
- (2017) Wei-yi Gong et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Regulation of cytotoxicity and apoptosis-associated pathways contributes to the enhancement of efficacy of cisplatin by baicalein adjuvant in human A549 lung cancer cells
- (2017) Suparata Kiartivich et al. Oncology Letters
- An Introduction to Terminology and Methodology of Chemical Synergy—Perspectives from Across Disciplines
- (2017) Kyle R. Roell et al. Frontiers in Pharmacology
- New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive Compounds
- (2017) Saúl Redondo-Blanco et al. Frontiers in Pharmacology
- p28-Mediated Activation of p53 in G 2 –M Phase of the Cell Cycle Enhances the Efficacy of DNA Damaging and Antimitotic Chemotherapy
- (2016) Tohru Yamada et al. CANCER RESEARCH
- Cyclin D1, cancer progression, and opportunities in cancer treatment
- (2016) Shuo Qie et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Baicalein Inhibits Epithelial to Mesenchymal Transition via Downregulation of Cyr61 and LOXL-2 in MDA-MB231 Breast Cancer Cells
- (2016) Linh Thi Thao Nguyen et al. MOLECULES AND CELLS
- Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells
- (2015) Yujun Wang et al. CANCER LETTERS
- Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2015) Gregory A. Masters et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cellular and clinical pharmacology of the taxanes docetaxel and paclitaxel – a review
- (2014) Vincent A. de Weger et al. ANTI-CANCER DRUGS
- Flavonoid components in Scutellaria baicalensis inhibit nicotine-induced proliferation, metastasis and lung cancer-associated inflammation in vitro
- (2014) WEI-YI GONG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Anticancer Effects of Baicalein on Hepatocellular Carcinoma Cells
- (2014) Yi-Hu Zheng et al. PHYTOTHERAPY RESEARCH
- Wnt Signaling Pathway in Non-Small Cell Lung Cancer
- (2013) D. J. Stewart JNCI-Journal of the National Cancer Institute
- Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation
- (2012) Ya-Hsin Cheng et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Targeting apoptosis pathways in cancer by Chinese medicine
- (2010) Min Li-Weber CANCER LETTERS
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
- (2008) Min Li-Weber CANCER TREATMENT REVIEWS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started